Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort StudyObservational Study Published on 2022-04-292022-10-05 Journal: Nutrients [Category] 임상, [키워드] 95% CI adjusted Admission age analyzed association B12 Clinical course Cohort composite endpoint coronavirus disease correlation correlation coefficient courses COVID-19 deficiencies deficiency eight Folic acid higher risk hospital hospital outcomes Hospitalized ICU in-hospital mortality intensive care IQR Logistic regression lower risk male Micronutrient micronutrients micronutrients. MOST older patient Patient Prevalence prevalent progression Research SARS-CoV-2 serum/plasma severe COVID-19 severe COVID-19 disease severe disease progression Treatment Vitamin vitamin A [DOI] 10.3390/nu14091862 PMC 바로가기 [Article Type] Observational Study
Clinical Improvement, Outcomes, Antiviral Activity, and Costs Associated With Early Treatment With Remdesivir for Patients With Coronavirus Disease 2019 (COVID-19)코로나바이러스 감염증 2019(COVID-19) 환자를 위한 렘데시비르의 조기 치료와 관련된 임상 개선, 결과, 항바이러스 활성 및 비용Article Published on 2022-04-282022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 진단, 치료제, [키워드] activity addition Admission Antiviral antiviral activity benefit changes in changes in viral load clinical Clinical deterioration Clinical improvement clinical outcomes Control cost COVID-19 COVID-19 patients Disease progression Follow-up groups Hong Kong hospital discharge Hospital stay Hospitalized hospitalized patient hospitalized patients IgG antibody improvement In-hospital death Inconclusive intensive care invasive ventilation lower risk median Mild-to-moderate Moderate COVID-19 multiple imputation on admission outcome oxygen Oxygen therapy Patient patients with COVID-19 positive progression Remdesivir retrospective cohort risk significantly shorter study outcomes the disease time Treatment Viral viral clearance Viral load WHO [DOI] 10.1093/cid/ciab631 PMC 바로가기 [Article Type] Article
Dynamics, outcomes and prerequisites of the first SARS-CoV-2 superspreading event in Germany in February 2020: a cross-sectional epidemiological study2020년 2월 독일 최초의 SARS-CoV-2 슈퍼확산 사건의 역학, 결과 및 전제 조건: 횡단면 역학 연구Article Published on 2022-04-062022-09-12 Journal: BMJ Open [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI age analysed asked average risk behavioural Blood children Community Complete condition COVID-19 cross-sectional dimensions distribution Dynamics Epidemiological study events Germany IgG ELISA indicate Infection infection control Lower lower risk North Older outbreak outcome participant Participants Pharyngeal swab questionnaire Questionnaires risk SARS-CoV-2 SARS-CoV-2 RT-PCR SARS-CoV-2-specific antibodies secondary secondary outcome smoking susceptibility Symptom took place Ventilation Virology [DOI] 10.1136/bmjopen-2021-059809 PMC 바로가기 [Article Type] Article
Is pregnancy a risk factor for in-hospital mortality in reproductive-aged women with SARS-CoV-2 infection? A nationwide retrospective observational cohort studyObservational Study Published on 2022-04-012022-10-05 Journal: International journal of gynaecology and obstetric [Category] COVID19(2023년), SARS, 임상, [키워드] acute respiratory syndrome adjusted age Analysis analyzed Brazil calculated Characteristics Co-infection coronavirus coronavirus disease coronavirus disease-2019 covariate COVID-19 database Factor favorable effect gestation hazard ratio hypothetical Immunosuppressed In-hospital death in-hospital mortality independent Infection inhibit Intervention lower risk Medical conditions Mortality multivariate Cox regression multivariate logistic regression Observational cohort study Odds ratio polymerase chain Pregnancy pregnant pregnant women Proinflammatory cytokine protective role reproductive retrospective risk factor SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome coronavirus 2 shown sociodemographic factors survival weaker immune response women [DOI] 10.1002/ijgo.14066 PMC 바로가기 [Article Type] Observational Study
The effect of previous oral anticoagulant use on clinical outcomes in COVID-19: A systematic review and meta-analysisShort communication Published on 2022-04-012022-10-05 Journal: The American journal of emergency medicine [Category] 임상, [키워드] adjusted Admission Anticoagulant anticoagulation article Clinical outcome conducted Controlled trial COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients database diagnosis of COVID-19 evaluate evaluate the effect Hospital admission ICU ICU admission intensive care lower risk Meta-analysis Mortality no decrease OAC Oral anticoagulation participant Patient prognosis of patient reducing representing risk statistical analysis systematic review therapy treated [DOI] 10.1016/j.ajem.2022.01.059 [Article Type] Short communication
Booster or additional vaccination doses in patients vaccinated against COVID-19COVID-19 예방 접종을 받은 환자의 추가 접종 또는 추가 접종Review Published on 2022-04-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 변종, [키워드] accelerate additional doses administer Administered administration adverse effect asked booster booster dose college Committee Consensus COVID COVID-19 COVID-19 vaccine criteria decrease deliberation dose doubt Efficacy English form group Health Health Organization higher risk immunocompromised individual immunocompromised individuals incompatible individual information Laboratory tests lack less lower risk moment mRNA mRNA vaccines observation period organizations Patient physician Population population groups question reduce risk SARS-CoV-2 Spanish spur the disease the vaccine third dose vaccinated against COVID-19 vaccination Vaccines variant virus World Health Organization [DOI] 10.37201/req/149.2021 PMC 바로가기 [Article Type] Review
Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US VeteransObservational Study Published on 2022-03-262022-10-05 Journal: Nicotine & tobacco research : official journal of [Category] Coronavirus, SARS, 임상, [키워드] 95% confidence interval 95%CI adjusted odds ratio advanced age Analysis association cascade Comorbidity complications Control COVID-19 current diabete Diabetes Mellitus examined Factor Factors former granular higher risk highlighting hospital Hospitalization Hospitalized in-hospital mortality increased risk Kidney disease logistic regression models lower risk Mortality nonsteroidal anti-inflammatory drug NSAIDS obesity outcome Patient patients with COVID-19 positive Presence primary analysis reported resource retrospective cohort study risk risk of death SARS-CoV-2 SARS-COV-2 infection smoker Smokers smoking smoking status status tested the United State Unknown variable veteran with COVID-19 [DOI] 10.1093/ntr/ntab223 PMC 바로가기 [Article Type] Observational Study
Social Distancing in Relation to Severe Exacerbations of Chronic Obstructive Pulmonary Disease: A Nationwide Semi-Experimental Study During the COVID-19 PandemicObservational Study Published on 2022-03-242022-10-05 Journal: American journal of epidemiology [Category] 임상, [키워드] 95% confidence interval acute exacerbation Admission Affect all-cause mortality chronic chronic obstructive chronic obstructive pulmonary disease clinical epidemiology Cohort cohort study COPD COPD exacerbations COVID-19 COVID-19 pandemic Denmark Exacerbation examined hazard ratio hospital incidence intensive care introduced lower risk measure Non-COVID-19 Patient pulmonary pulmonary disease relation respiratory infections resulting risk risk reduction social distancing sub-cohort subdistribution was reduced [DOI] 10.1093/aje/kwab292 PMC 바로가기 [Article Type] Observational Study
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience중화 모노클로날 항체 치료로 경증 및 중등도 코로나바이러스 질병 2019(COVID-19)로 인한 입원 감소: 실제 경험Article Published on 2022-03-232022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] adjusted adult COVID-19 patient age Analysis authorization BAM BMI Clinical practice Control controls COVID-19 COVID-19 patient Efficacy Emergency experience groups hospital Hospitalization Hospitalized identify Immunotherapy Infection inpatient care lower risk medical record Mild Moderate COVID-19 monoclonal antibody Mortality Multimorbidity not different Patient receiving reduced REGN-CoV2 reported resource resource utilization. SARS-CoV-2 Sex significantly significantly lower survival symptom onset treat Treatment were used [DOI] 10.1093/cid/ciab579 PMC 바로가기 [Article Type] Article
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 5050세 이상의 사람들에서 Covid-19에 대한 BNT162b2 및 ChAdOx1 백신의 비교 효과Article Published on 2022-03-212022-09-11 Journal: Nature Communications [Category] SARS, 변종, 임상, 치료법, [키워드] 95% CI BNT162b2 booster ChAdOx1 ChAdOx1 vaccine Comparative Cox model delta variant dominant dose Effectiveness Efficacy hazard ratio head Head-to-head comparison hospitalisation Infection inverse lower risk mRNA of BNT162b2 Older participant persist Population Probability risk SARS-COV-2 infection study period Trial UK biobank vaccination Vaccine Vaccines Weighting [DOI] 10.1038/s41467-022-29159-x PMC 바로가기 [Article Type] Article